Heart failure & cardiomyopathies

Conduction system pacing compared with biventricular pacing for cardiac resynchronization therapy in patients with heart failure and mildly reduced left ventricular ejection fraction: Results from International Collaborative LBBAP Study (I-CLAS) Group

Heart RhythmPublished Retrospective cohort study

Main finding · Death or HFHResult — go to the resultHazard ratio 0.64 95% CI 0.43–0.94

Authors' conclusion

CSP was associated with improved clinical outcomes compared with BVP in this large cohort of patients with HFmrEF undergoing CRT.

Study context

Population
Patients with heart failure with mildly reduced ejection fraction (HFmrEF) (left ventricular ejection fraction (LVEF) 36%-50%) undergoing cardiac resynchronization therapy (CRT), January 2018 to June 2023
Participants
1,004 patients
Exposure
Conduction system pacing (CSP) vs biventricular pacing (BVP) for CRT
  • CSPn = 826
  • BVPn = 178reference
Outcome
Composite of:
  • Time to death
  • HF hospitalization (heart failure hospitalization (HFH))
Methodological detailsmulticentre, 16 international centres, consecutive patients
  • Multicentre
  • 16 international centres
  • Consecutive patients

Main finding

Death or HFH

Hazard ratio

0.64

95% CI 0.43–0.94

P = 0.025

By group

CSP vs BVP
HR 0.64 (95% CI 0.43–0.94); P = 0.025

As reported in the abstract

Observational data: associations, not effects.

Secondary outcomes

Paced QRS duration · significantly narrower with CSP

P < 0.001

OutcomeCSPBVPP value
LVEF during follow-up49% (SD 10%)48% (SD 10%)P = 0.32

LVEF during follow-up

LVEF improved in both groups

Original publication

Conduction system pacing compared with biventricular pacing for cardiac resynchronization therapy in patients with heart failure and mildly reduced left ventricular ejection fraction: Results from International Collaborative LBBAP Study (I-CLAS) Group. Heart Rhythm. Published 27 September 2024. doi:10.1016/j.hrthm.2024.09.030

Summarised from the published abstract; every number is checked against it

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.